Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001047469-13-006837
Filing Date
2013-06-07
Accepted
2013-06-07 17:10:18
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1/A a2215479zs-1a.htm S-1/A 2001745
2 EX-3.4 a2215479zex-3_4.htm EX-3.4 152729
3 EX-10.11 a2215479zex-10_11.htm EX-10.11 18808
4 EX-23.1 a2215479zex-23_1.htm EX-23.1 2611
6 G939471.JPG g939471.jpg GRAPHIC 31133
7 G679275.JPG g679275.jpg GRAPHIC 20480
8 G490766.JPG g490766.jpg GRAPHIC 54950
9 filename9.htm CORRESP 23486
  Complete submission text file 0001047469-13-006837.txt   2347741
Mailing Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170
Business Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170 734-862-4840
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-188595 | Film No.: 13901422
SIC: 2834 Pharmaceutical Preparations